Company facts
- Industry
- Pharmaceutical Preparations
- Headquarters
- Vancouver
- Most recent report
- 10-Q, filed Nov 9, 2026
- Incorporated
- N/A
- Filings on record
- 324 filings
- On EDGAR
- CIK 1703057
- Fiscal year ends
- December
- Filer status
- Large accelerated filer
Financials 8 of 25
News 8 of 64
Prospectuses and Registrations 8 of 29
- 424B5 Prospectus supplement for an offering Aug 13, 2026
- 424B5 Prospectus supplement for an offering Aug 11, 2026
- S-8 Registration statement for an employee plan Feb 24, 2026
- S-3ASR Automatic shelf registration Feb 27, 2025
- S-8 Registration statement for an employee plan Feb 27, 2025
- S-8 Registration statement for an employee plan Feb 20, 2024
- S-8 Registration statement for an employee plan Feb 21, 2023
- POS AM Post-effective amendment to a registration Jul 22, 2022
Proxies 8 of 12
- DEFA14A Extra proxy material Apr 29, 2026
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2026
- DEFA14A Extra proxy material Apr 29, 2025
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2025
- DEFA14A Extra proxy material Apr 29, 2024
- DEF 14A Proxy statement for a shareholder vote Apr 29, 2024
- DEFA14A Extra proxy material Apr 28, 2023
- DEF 14A Proxy statement for a shareholder vote Apr 28, 2023
Ownership 8 of 162
- 4 Insider reported a trade Aug 24, 2026
- 4 Insider reported a trade Aug 18, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 14, 2026
- 4 Insider reported a trade Aug 13, 2026
- 4 Insider reported a trade Jul 6, 2026
- 3 Insider reported their initial holding Jul 6, 2026
- 4 Insider reported a trade Jul 6, 2026
Other 8 of 32
- ARS Annual report sent to shareholders Apr 29, 2026
- ARS Annual report sent to shareholders Apr 29, 2025
- ARS Annual report sent to shareholders Apr 29, 2024
- ARS Annual report sent to shareholders Apr 28, 2023
- EFFECT Notice that a registration became effective Aug 11, 2022
- UPLOAD Comment letter from SEC staff Jul 28, 2022
- CORRESP Reply to SEC staff Jul 22, 2022
- UPLOAD Comment letter from SEC staff Jul 14, 2022
Everything here comes from AbCellera Biologics Inc.'s own filings on SEC EDGAR. The filing list is rechecked every hour.